These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 32380)

  • 1. [Influence of the route of administration on the metabolism of a beta-adrenergic blocker, o-[3-(tert-butylamino)-2-hydroxypropoxy]-benzonitrile (bunitrolol) (author's transl)].
    Rikihisa T; Toyama S; Mori M; Suzuki T
    Yakugaku Zasshi; 1978 Sep; 98(9):1258-66. PubMed ID: 32380
    [No Abstract]   [Full Text] [Related]  

  • 2. Antihypertensive effect of intravenously and orally administered bunitrolol (Kö 1366).
    Okabayashi T; Naito S; Arakawa K
    Arzneimittelforschung; 1979; 29(9):1417-21. PubMed ID: 42418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparable ergometric examinations before and after administration of practolol and bunitrolol (author's transl)].
    Pozenel H
    Wien Klin Wochenschr; 1975 Jan; 87(1):19-25. PubMed ID: 236621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical investigation of o-(2-hydroxy-3-(tert.-butylamino)-propoxy)-benzonitrile under glucose load by means of continuous recording].
    Regula H; Papner B
    Arzneimittelforschung; 1974 Sep; 24(9):1328-30. PubMed ID: 4154767
    [No Abstract]   [Full Text] [Related]  

  • 5. [The metabolism of 1-tertiary-butylamino-3-(2,3-dimethylphenoxy)-2-propanol (D-32), a new beta-blocker agent. II. Blood level, distribution, and structure of its metabolites in bile (author's transl)].
    Honma S; Kanbekawa A
    Yakugaku Zasshi; 1975 Jun; 95(6):680-9. PubMed ID: 241825
    [No Abstract]   [Full Text] [Related]  

  • 6. [The pharmacokinetics of 1-(4-cyclohexylureidophenoxy)-2-hydroxy-3-tert-butylaminopropane (talinolol, Cordanum, 02-115) 2. Excretion, blood level and distribution of the 14C-labeled compound in the rat].
    Klemm W; Wenzel A
    Pharmazie; 1975 Oct; 30(10):675-7. PubMed ID: 695
    [No Abstract]   [Full Text] [Related]  

  • 7. A double blind cross-over comparison of bunitrolol and placebo in the treatment of angina pectoris.
    Jonker JJ; de Klerk J; den Ottolander GJ
    Arzneimittelforschung; 1981; 31(7):1140-2. PubMed ID: 6115654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolation and characterization of metabolites derived from 1-tert-butylamino-3-(2,3-dimethylphenoxy)-2-propanol (D-32), a new beta-blocker.
    Honma S; Kambekawa A
    Chem Pharm Bull (Tokyo); 1975 May; 23(5):1045-56. PubMed ID: 241494
    [No Abstract]   [Full Text] [Related]  

  • 9. Pharmacokinetics of the new beta-adrenoceptor blocker SL 75212 in man after repeated oral administration [proceedings].
    Bianchetti G; Blatrix C; Gomeni R; Kilborn JR; Larribaud J; Lücker PW; Morselli PL; Thébault JJ; Trocherie S
    Br J Clin Pharmacol; 1979 Oct; 8(4):408P. PubMed ID: 41560
    [No Abstract]   [Full Text] [Related]  

  • 10. [The effect of a short-term oral administration of trimepranol on plasma renin activity (author's transl)].
    Slabý A; Dosková M; Horký K; Urbánek J; Reiseauer R
    Sb Lek; 1975 Apr; 77(4):102-6. PubMed ID: 238277
    [No Abstract]   [Full Text] [Related]  

  • 11. [The pharmacokinetics of 1-(4-cyclohexylureidophenoxy)-2-hydroxy-3-tert-butylaminopropane (talinolol, Cordanum, 02-115). 1. Blood levels in dogs].
    Femmer K; Klemm W; Nürnberger H
    Pharmazie; 1975 Oct; 30(10):673-5. PubMed ID: 694
    [No Abstract]   [Full Text] [Related]  

  • 12. [Synthesis of 5-(3-tert-butylamino-2-hydroxypropoxy)-8-hydroxy-3,4-dihydrocarbostyril hydrochloride and its beta-adrenergic blocking activity].
    Uchida M; Tominaga M; Oka K; Tone H; Uno T
    Yakugaku Zasshi; 1976 May; 96(5):571-7. PubMed ID: 9501
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacokinetics of betaxolol in middle aged patients.
    Bianchetti G; Thiercelin JF; Thenot JP
    Eur J Clin Pharmacol; 1986; 31(2):231-3. PubMed ID: 2879735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparison of the haemodynamic effects in man of the beta-adrenergic blocking substances Kö 1366 and practolol (author's transl)].
    Gloger K
    Arzneimittelforschung; 1975 Aug; 25(8):1300-3. PubMed ID: 241365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stereoselectivity in the metabolism of the beta-adrenergic blocking agent, (+/-)-1-tert-butylamino-3-(2,3-dimethylphenoxy)-2-propanol hydrochloride (xibenolol hydrochloride, D-32), in man.
    Honma S; Ito T; Kambegawa A
    Chem Pharm Bull (Tokyo); 1985 Feb; 33(2):760-8. PubMed ID: 2861914
    [No Abstract]   [Full Text] [Related]  

  • 16. Characterization of beta-adrenoceptors on rat skeletal muscle cells grown in vitro.
    Disatnik MH; Sampson SR; Shainberg A
    Biochem Pharmacol; 1990 Sep; 40(5):1043-8. PubMed ID: 1975171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Circulatory effects of a new specific beta adrenergic blocking agent, (o-(2-hydroxy-3-(tert. butylamino)-propoxyl)-benzonitrile, Kö 1366)].
    Gilfrich HJ; Rahn KH; Nicolescu RF
    Arzneimittelforschung; 1973 Jun; 23(6):768-71. PubMed ID: 4146902
    [No Abstract]   [Full Text] [Related]  

  • 18. [Stereoselective glucuronidation of beta-blocking agents, 1-tert-butylamino-3-(2,3-dimethylphenoxy)-2-propanol (D-32) and propranolol, in animals, in vivo and in vitro].
    Honma S; Ito T; Matsuki Y
    Yakugaku Zasshi; 1986 May; 106(5):406-13. PubMed ID: 2876088
    [No Abstract]   [Full Text] [Related]  

  • 19. Blood concentrations and pharmacodynamic effects of SL 75212, a new beta-adrenoceptor antagonist, after oral and intravenous administration [proceedings].
    Bianchetti G; Gomeni R; Kilborn JR; Morselli PL; Taylor EA; Warrington SJ
    Br J Clin Pharmacol; 1979 Oct; 8(4):403P-404P. PubMed ID: 41556
    [No Abstract]   [Full Text] [Related]  

  • 20. [Synthesis of optically active 5- (3-tert-butylamino-2-hydroxypropoxy)-3,4-dihydrocarbostyril hydrochloride and their beta-adrenergic blocking activities (author's transl)].
    Yamamoto K; Uno T; Ishihara T; Nakagawa K
    Yakugaku Zasshi; 1976 Mar; 96(3):289-92. PubMed ID: 784944
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.